Cargando…

Comparison Between Early-Onset and Common Gout: A Systematic Literature Review

INTRODUCTION: Gout is an inflammatory, metabolic disease associated with a high comorbidity burden including cardiovascular disease, hypertension, type 2 diabetes, hyperlipidemia, renal disease, and metabolic syndrome. Approximately 9.2 million Americans have gout, making prognosis and treatment out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amatucci, Anthony J., Padnick-Silver, Lissa, LaMoreaux, Brian, Bulbin, David H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326179/ https://www.ncbi.nlm.nih.gov/pubmed/37335432 http://dx.doi.org/10.1007/s40744-023-00565-x

Ejemplares similares

Enhancing the Response Rate to Recombinant Uricases in Patients with Gout
por: Schlesinger, Naomi, et al.
Publicado: (2022)

Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study
por: Masri, Karim Richard, et al.
Publicado: (2022)

Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout
por: Broadwell, Aaron, et al.
Publicado: (2022)

Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
por: Francis-Sedlak, Megan, et al.
Publicado: (2020)

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12‐Month Findings
por: Botson, John K., et al.
Publicado: (2023)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
por: Khanna, Puja, et al.
Publicado: (2020)

Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases
por: Morton, Allan H., et al.
Publicado: (2018)

Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study
por: Albert, John A., et al.
Publicado: (2020)

New-Onset Gout as an Independent Risk Factor for Returning to Dialysis After Kidney Transplantation
por: Li, Justin W., et al.
Publicado: (2020)

Comparison of Rates of Lower Extremity Amputation in Patients With and Without Gout in the US Department of Veterans Affairs Health System
por: Mikuls, Ted R., et al.
Publicado: (2022)

Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial
por: Botson, John K., et al.
Publicado: (2022)

Comparison of Two Corticosteroid Pre-Infusion Regimens for Pegloticase in the United States: A Retrospective Analysis in Community Rheumatology Practices
por: Majjhoo, Amar, et al.
Publicado: (2019)

A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney Transplantation
por: Li, Justin W., et al.
Publicado: (2020)

SAT-424 Assessing Content Validity of the Graves’ Ophthalmopathy Quality of Life Questionnaire (GO-QOL) in the United States
por: Stan, Marius N, et al.
Publicado: (2020)

Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase
por: Keenan, Robert T., et al.
Publicado: (2019)

Common dysfunctional variants in ABCG2 are a major cause of early-onset gout
por: Matsuo, Hirotaka, et al.
Publicado: (2013)

Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
por: Cockerham, Kimberly P., et al.
Publicado: (2021)

Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
por: Cockerham, Kimberly P., et al.
Publicado: (2022)

Clinical Characteristics of Early‐Onset Gout in Outpatient Setting
por: Li, Yan, et al.
Publicado: (2019)

A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings
por: Botson, John K., et al.
Publicado: (2022)

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
por: Arezzo, Joseph C, et al.
Publicado: (2008)

Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States
por: Wang, Yao, et al.
Publicado: (2020)

Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States
por: Wang, Yao, et al.
Publicado: (2020)

Clinical characteristics of early- and late-onset gout: A cross-sectional observational study from a Chinese gout clinic
por: Zhang, Bingqing, et al.
Publicado: (2016)

The anatomical pathology of gout: a systematic literature review
por: Towiwat, Patapong, et al.
Publicado: (2019)

Early onset gout and chronic kidney disease in a young female patient
por: Cao, Yu, et al.
Publicado: (2021)

A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study
por: Botson, John K., et al.
Publicado: (2022)

Juvenile-onset gout and adipsic diabetes insipidus: A case report and literature review
por: Zhang, Yun, et al.
Publicado: (2018)

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout
por: Murdoch, Rachel, et al.
Publicado: (2021)

Genetic Background of a Juvenile Onset Gout Patient
por: Zhang, Yun, et al.
Publicado: (2018)

Young Onset Polyarticular Tophaceous Gout: Rare and Aggressive
por: Rana, Deepshikha, et al.
Publicado: (2021)

Differences in Clinical and Dietary Characteristics, Serum Adipokine Levels, and Metabolomic Profiles between Early- and Late-Onset Gout
por: Suh, Young Sun, et al.
Publicado: (2021)

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
por: Kvasnička, Aleš, et al.
Publicado: (2023)

Gouty tophus erodes nasal bone
por: Rottmann, Eva, et al.
Publicado: (2021)

Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout
por: Toyoda, Yu, et al.
Publicado: (2021)

Gout of the temporomandibular joint and review of the literature
por: Hng, Joel, et al.
Publicado: (2022)

Gout. Epidemiology of gout
por: Roddy, Edward, et al.
Publicado: (2010)

Untangling the relationship between bempedoic acid and gout: results from a systematic literature review
por: Alunno, Alessia, et al.
Publicado: (2023)

The nurse's role in managing gout in the modern era: A systematic review of the literature
por: Tsiamalou, Paraskevi, et al.
Publicado: (2023)

Multiple common and rare variants of ABCG2 cause gout
por: Higashino, Toshihide, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_io4t8ke46i8etl2dm0bstmaj4m